PEMBROKE PINES, Fla., April 12, 2005 (PRIMEZONE) -- Chaichem Holdings, Inc. (Pink Sheets:CIMH), a biotech research and development company, announced that it has received a ticker symbol and begun publicly trading.
"We are in the midst of exploring some very interesting opportunities and access to the public markets provides us with a forum to get additional exposure for the exciting ongoing events at the Company," remarked Chaichem Vice President Dean Ward. "We have achieved another significant milestone in bringing the Company public and look forward to providing updates on some of our other additional ongoing activities in the near future as things continue to progress."
The Company
Chaichem Holdings, Inc. is a biotech development company, publicly traded under the ticker symbol CIMH. Chaichem is pursuing synergistic, value-added opportunities in the biotech field with the potential for achieving high-growth returns for our investors.
This news release contains forward-looking statements regarding Chaichem's business strategies and future plans of operations. Forward-looking statements involve known and unknown risk and uncertainties. The company's risks and uncertainties include: intense price competition, economic, political and regulatory uncertainties, the need to raise additional capital for growth and expansion and its reliance on the internet as a means for promoting the software it sublicenses. The forward-looking statements contained in this news release speak only as of the date hereof and Chaichem disclaims any obligation to provide public updates, revisions or amendments to any forward-looking statements made herein to reflect changes in Chaichem's expectations or future events.